Ledger.Open graph →
SEC Form D · filed January 28, 2025

Kairos Pharma, LTD

Offering
$8.8M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LOS ANGELES, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Hyun W. Bae · DEL MAR, CADirectorNeil S. Bhowmick · Los Angeles, CAExecJohn S. Yu · Woodland Hills, CAExec · DirectorHansoo Michael W. Keyoung · Los Angeles, CADirectorRamachandran S. Murali · Los Angeles, CAExecDoug S. Samuelson · Los Angeles, CAExecRahul W. Singhvi · Los Angeles, CADirectorHyun W. Bae · DEL MAR, CADirectorNeil S. Bhowmick · Los Angeles, CAExecJohn S. Yu · Los Angeles, CAExec · DirectorHansoo Michael W. Keyoung · Los Angeles, CADirectorRamachandran S. Murali · Los Angeles, CAExecDoug S. Samuelson · Los Angeles, CAExecRahul W. Singhvi · Los Angeles, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗